School of Medicine
Showing 1-10 of 34 Results
Professor of Pediatrics (Hematology/Oncology) and of Medicine
Current Research and Scholarly Interests Recent clinical studies, by us and others, have demonstrated unequivocally that T cell based immunotherapy can eradicate cancers resistant to all other available therapies. Our program is focused on using genetically engineered T cells to treat cancer. We link the bench with the bedside, developing novel therapies for early phase testing in clinical trials, as well as conducting intensive studies on clinical samples obtained from patients treated on immunotherapy trials.
Sean Mackey, MD, PhD
Redlich Professor and Professor, by courtesy, of Neurology at the Stanford University Medical Center
Current Research and Scholarly Interests Functional neuroimaging of pain. Imaging of cognitive and affective dimensions of pain, neural plasticity contributing to chronic pain and effects of treatment.
Effects of membrane stabilizing medications on neuropathic pain.
Chronic pain outcomes tools development and measurement.
Shannon MacLaughlan David
Clinical Assistant Professor, Obstetrics & Gynecology - Gynecologic Oncology
Bio Dr. Shannon MacLaughlan David specializes in the care of women with cancers unique to women (eg, ovarian, cervix, uterine and vulva cancers among others). She takes a holistic approach to providing care for her patients, remembering that there is more to a woman than her cancer. Dr. MacLaughlan David is experienced in caring for women in all phases of their lives, including the rare adolescents and young adults with gynecologic cancers. She has special interests in minimally invasive surgery, education and professional mentorship.
Associate Professor (Research) of Microbiology and Immunology
Current Research and Scholarly Interests I'm interested in immune monitoring of T cell responses to chronic pathogens such as CMV, and the correlation of T cell response signatures with disease protection.
Ravi Majeti MD, PhD
Associate Professor of Medicine (Hematology)
Current Research and Scholarly Interests The Majeti lab focuses on the molecular/genomic characterization and therapeutic targeting of leukemia stem cells in human hematologic malignancies, particularly acute myeloid leukemia (AML). Our lab uses experimental hematology methods, stem cell assays, genome editing, and bioinformatics to define and investigate drivers of leukemia stem cell behavior. As part of these studies, we have led the development and application of robust xenotransplantation assays for human hematopoietic cells.
Sanjay V. Malhotra, PhD
Associate Professor (Research) of Radiation Oncology (Radiation and Cancer Biology) and of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly Interests My research interests focus on the design and discovery of synthetic, and natural product inspired small molecules which can be used as probes for developing understanding of biological phenomena, including protein-protein interactions and modulation of signal transduction pathways. My laboratory employs the tools of synthetic medicinal chemistry, molecular modeling and chemical biology for translational research in drug discovery, development, imaging and radiation.
Assistant Professor (Research) of Radiology (General Radiology)
Current Research and Scholarly Interests The Mallick Lab is focused on using integrative, multi-omic approaches to model the processes that govern proteome dynamics and to use those models to discover cancer biomarkers and molecular mechanisms.
Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital
Current Research and Scholarly Interests Germ cell tumors and bone sarcomas.
M. Peter Marinkovich, MD
Associate Professor of Dermatology
Current Research and Scholarly Interests The Marinkovich lab studies the function of epithelial extracellular matrix molecules, including integrins, collagens and laminins in epithelial development and carcinoma progression. We apply our discoveries in this area towards development of molecular therapies for carcinomas, hair disease and inherited epithelial adhesive disorders.